Oligomeric and Conformational Properties of a Proteolytically Mature, Disulfide-stabilized Human Immunodeficiency Virus Type 1 Gp140 Envelope Glycoprotein

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2002 Jul 5

PMID 12097589

Citations 88

Authors

Norbert Schulke

Mika S Vesanen

Rogier W Sanders

Ping Zhu

Min Lu

Deborah J Anselma

Anthony R Villa

Paul W H I Parren

James M Binley

Kenneth H Roux

Paul J Maddon

John P Moore

William C Olson

Affiliations

Soon will be listed here.

Abstract

We describe the further properties of a protein, designated SOS gp140, wherein the association of the gp120 and gp41 subunits of the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein is stabilized by an intersubunit disulfide bond. HIV-1(JR-FL) SOS gp140, proteolytically uncleaved gp140 (gp140(UNC)), and gp120 were expressed in stably transfected Chinese hamster ovary cells and analyzed for antigenic and structural properties before and after purification. Compared with gp140(UNC), SOS gp140 reacted more strongly in surface plasmon resonance and radioimmunoprecipitation assays with the neutralizing monoclonal antibodies (MAbs) 2G12 (anti-gp120), 2F5 (anti-gp41), and 17b (to a CD4-induced epitope that overlaps the CCR5-binding site). In contrast, gp140(UNC) displayed the greater reactivity with nonneutralizing anti-gp120 and anti-gp41 MAbs. Immunoelectron microscopy studies suggested a model for SOS gp140 wherein the gp41 ectodomain (gp41(ECTO)) occludes the "nonneutralizing" face of gp120, consistent with the antigenic properties of this protein. We also report the application of Blue Native polyacrylamide gel electrophoresis (BN-PAGE), a high-resolution molecular sizing method, to the study of viral envelope proteins. BN-PAGE and other biophysical studies demonstrated that SOS gp140 was monomeric, whereas gp140(UNC) comprised a mixture of noncovalently associated and disulfide-linked dimers, trimers, and tetramers. The oligomeric and conformational properties of SOS gp140 and gp140(UNC) were largely unaffected by purification. An uncleaved gp140 protein containing the SOS cysteine mutations (SOS gp140(UNC)) was also oligomeric. Surprisingly, variable-loop-deleted SOS gp140 proteins were expressed (although not yet purified) as cleaved, noncovalently associated oligomers that were significantly more stable than the full-length protein. Overall, our findings have relevance for rational vaccine design.

Citing Articles

Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation.

Ding H, Nguyen H, Li W, Deshpande A, Zhang S, Jiang F J Virol. 2024; 98(12):e0172024.

PMID: 39508605 PMC: 11650979. DOI: 10.1128/jvi.01720-24.

The Question of HIV Vaccine: Why Is a Solution Not Yet Available?.

Libera M, Caputo V, Laterza G, Moudoud L, Soggiu A, Bonizzi L J Immunol Res. 2024; 2024:2147912.

PMID: 38628675 PMC: 11019575. DOI: 10.1155/2024/2147912.

Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation.

Zhang Z, Wang Q, Nguyen H, Chen H, Chiu T, Smith Iii A J Virol. 2023; 97(9):e0059223.

PMID: 37696048 PMC: 10537687. DOI: 10.1128/jvi.00592-23.

SARS-CoV-2 S Glycoprotein Stabilization Strategies.

Pedenko B, Sulbaran G, Guilligay D, Effantin G, Weissenhorn W Viruses. 2023; 15(2).

PMID: 36851772 PMC: 9960574. DOI: 10.3390/v15020558.

Characterization of the Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Conformational States on Infectious Virus Particles.

Nguyen H, Wang Q, Anang S, Sodroski J J Virol. 2023; 97(3):e0185722.

PMID: 36815832 PMC: 10062176. DOI: 10.1128/jvi.01857-22.

References

Melikyan G, Markosyan R, Hemmati H, Delmedico M, Lambert D, Cohen F . Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol. 2000; 151(2):413-23. PMC: 2192659. DOI: 10.1083/jcb.151.2.413. View

Farzan M, Choe H, DESJARDINS E, Sun Y, Kuhn J, Cao J . Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain. J Virol. 1998; 72(9):7620-5. PMC: 110020. DOI: 10.1128/JVI.72.9.7620-7625.1998. View

Earl P, Sugiura W, Montefiori D, Broder C, Lee S, Wild C . Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140. J Virol. 2001; 75(2):645-53. PMC: 113961. DOI: 10.1128/JVI.75.2.645-653.2001. View

Jones P, Korte T, Blumenthal R . Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. J Biol Chem. 1998; 273(1):404-9. DOI: 10.1074/jbc.273.1.404. View

Zhu P, Olson W, Roux K . Structural flexibility and functional valence of CD4-IgG2 (PRO 542): potential for cross-linking human immunodeficiency virus type 1 envelope spikes. J Virol. 2001; 75(14):6682-6. PMC: 114391. DOI: 10.1128/JVI.75.14.6682-6686.2001. View

Vancott T, Mascola J, Kaminski R, Kalyanaraman V, Hallberg P, Burnett P . Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160. J Virol. 1997; 71(6):4319-30. PMC: 191648. DOI: 10.1128/JVI.71.6.4319-4330.1997. View

Roux . Negative-Stain Immunoelectron-Microscopic Analysis of Small Macromolecules of Immunologic Significance. Methods. 1996; 10(2):247-56. DOI: 10.1006/meth.1996.0099. View

Binley J, Sanders R, CLAS B, Schuelke N, Master A, Guo Y . A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J Virol. 2000; 74(2):627-43. PMC: 111582. DOI: 10.1128/jvi.74.2.627-643.2000. View

York J, Follis K, Trahey M, Nyambi P, Zolla-Pazner S, Nunberg J . Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1. J Virol. 2001; 75(6):2741-52. PMC: 115898. DOI: 10.1128/JVI.75.6.2741-2752.2001. View

10.

Ferlenghi I, Gowen B, de HAAS F, Mancini E, Garoff H, Sjoberg M . The first step: activation of the Semliki Forest virus spike protein precursor causes a localized conformational change in the trimeric spike. J Mol Biol. 1998; 283(1):71-81. DOI: 10.1006/jmbi.1998.2066. View

11.

BERMAN P, Gregory T, Riddle L, NAKAMURA G, Champe M, Porter J . Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature. 1990; 345(6276):622-5. DOI: 10.1038/345622a0. View

12.

Dutch R, Hagglund R, Nagel M, PATERSON R, Lamb R . Paramyxovirus fusion (F) protein: a conformational change on cleavage activation. Virology. 2001; 281(1):138-50. DOI: 10.1006/viro.2000.0817. View

13.

Chan D, Fass D, Berger J, Kim P . Core structure of gp41 from the HIV envelope glycoprotein. Cell. 1997; 89(2):263-73. DOI: 10.1016/s0092-8674(00)80205-6. View

14.

Earl P, Doms R, Moss B . Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc Natl Acad Sci U S A. 1990; 87(2):648-52. PMC: 53322. DOI: 10.1073/pnas.87.2.648. View

15.

BERMAN P, Nunes W, Haffar O . Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell lines. J Virol. 1988; 62(9):3135-42. PMC: 253430. DOI: 10.1128/JVI.62.9.3135-3142.1988. View

16.

Cherpelis S, Shrivastava I, Gettie A, Jin X, Ho D, Barnett S . DNA vaccination with the human immunodeficiency virus type 1 SF162DeltaV2 envelope elicits immune responses that offer partial protection from simian/human immunodeficiency virus infection to CD8(+) T-cell-depleted rhesus macaques. J Virol. 2001; 75(3):1547-50. PMC: 114060. DOI: 10.1128/JVI.75.3.1547-1550.2001. View

17.

Moore J, Willey R, LEWIS G, Robinson J, Sodroski J . Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1. J Virol. 1994; 68(11):6836-47. PMC: 237119. DOI: 10.1128/JVI.68.11.6836-6847.1994. View

18.

Tan K, Liu J, Wang J, Shen S, Lu M . Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci U S A. 1997; 94(23):12303-8. PMC: 24915. DOI: 10.1073/pnas.94.23.12303. View

19.

Caffrey M, Kaufman J, Stahl S, Wingfield P, Gronenborn A, Clore G . Monomer-trimer equilibrium of the ectodomain of SIV gp41: insight into the mechanism of peptide inhibition of HIV infection. Protein Sci. 1999; 8(9):1904-7. PMC: 2144406. DOI: 10.1110/ps.8.9.1904. View

20.

Parren P, Burton D . The antiviral activity of antibodies in vitro and in vivo. Adv Immunol. 2001; 77:195-262. PMC: 7131048. DOI: 10.1016/s0065-2776(01)77018-6. View